MA51990A - Formulations hautement stables d'hormone thyroïdienne dans des capsules molles - Google Patents
Formulations hautement stables d'hormone thyroïdienne dans des capsules mollesInfo
- Publication number
- MA51990A MA51990A MA051990A MA51990A MA51990A MA 51990 A MA51990 A MA 51990A MA 051990 A MA051990 A MA 051990A MA 51990 A MA51990 A MA 51990A MA 51990 A MA51990 A MA 51990A
- Authority
- MA
- Morocco
- Prior art keywords
- highly stable
- soft capsules
- thyroid hormone
- hormone formulations
- stable thyroid
- Prior art date
Links
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000007901 soft capsule Substances 0.000 title 1
- 239000005495 thyroid hormone Substances 0.000 title 1
- 229940036555 thyroid hormone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102018000003615A IT201800003615A1 (it) | 2018-03-15 | 2018-03-15 | Formulazioni altamente stabili di ormone tiroideo in capsule molli |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA51990A true MA51990A (fr) | 2021-04-07 |
Family
ID=62530409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA051990A MA51990A (fr) | 2018-03-15 | 2019-03-06 | Formulations hautement stables d'hormone thyroïdienne dans des capsules molles |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11717486B2 (fr) |
| EP (1) | EP3764984B1 (fr) |
| CN (2) | CN118059054A (fr) |
| CA (1) | CA3094384A1 (fr) |
| DK (1) | DK3764984T3 (fr) |
| ES (1) | ES2898387T3 (fr) |
| HR (1) | HRP20211717T1 (fr) |
| HU (1) | HUE056416T2 (fr) |
| IT (1) | IT201800003615A1 (fr) |
| MA (1) | MA51990A (fr) |
| PL (1) | PL3764984T3 (fr) |
| PT (1) | PT3764984T (fr) |
| RU (1) | RU2020128269A (fr) |
| WO (1) | WO2019174990A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3171512A1 (fr) * | 2020-03-18 | 2022-09-23 | Rickey Steve Shelley | Capsules de gel mou |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19541128C2 (de) * | 1995-10-27 | 1997-11-27 | Henning Berlin Gmbh & Co | Stabilisierte schilddrüsenhormonhaltige Arzneimittel |
| US6214376B1 (en) * | 1998-08-25 | 2001-04-10 | Banner Pharmacaps, Inc. | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
| AU2004201566A1 (en) * | 1999-07-07 | 2004-05-06 | R. P. Scherer Technologies, Inc. | Film Forming Compositions Comprising Modified Starches and Iota-carrageenan and Methods for Manufacturing Soft Capsules Using Same |
| EP1335710B8 (fr) * | 2000-11-09 | 2007-02-28 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Capsules souples comprenant un melange d'amidon a degre de ramification reduit |
| ITMI20011401A1 (it) | 2001-07-02 | 2003-01-02 | Altergon Sa | Formulazioni farmaceutiche per ormoni tiroidei |
| NZ539900A (en) * | 2002-11-07 | 2008-03-28 | Advanced Bionutrition Corp | Nutraceuticals and method of feeding aquatic animals |
| GB0316206D0 (en) * | 2003-07-10 | 2003-08-13 | Glaxo Group Ltd | Pharmaceutical formulation |
| CN1820783A (zh) * | 2005-02-17 | 2006-08-23 | 阿尔特贡股份公司 | 甲状腺激素药物制剂 |
| CN101180097A (zh) * | 2005-05-26 | 2008-05-14 | 症变治疗公司 | 新型含次膦酸的拟甲状腺素药 |
| ITMI20112221A1 (it) * | 2011-12-05 | 2013-06-06 | Altergon Sa | Formulazioni stabili in capsule di gelatina molle di antiaggreganti piastrinici, acidi grassi omega-3 e amilosio |
| EP2885005B1 (fr) * | 2012-08-20 | 2017-09-27 | Merck Patent GmbH | Préparation pharmaceutique solide contenant de la lévothyroxine |
-
2018
- 2018-03-15 IT IT102018000003615A patent/IT201800003615A1/it unknown
-
2019
- 2019-03-06 WO PCT/EP2019/055547 patent/WO2019174990A1/fr active Application Filing
- 2019-03-06 MA MA051990A patent/MA51990A/fr unknown
- 2019-03-06 HU HUE19708112A patent/HUE056416T2/hu unknown
- 2019-03-06 ES ES19708112T patent/ES2898387T3/es active Active
- 2019-03-06 RU RU2020128269A patent/RU2020128269A/ru unknown
- 2019-03-06 DK DK19708112.8T patent/DK3764984T3/da active
- 2019-03-06 PT PT197081128T patent/PT3764984T/pt unknown
- 2019-03-06 PL PL19708112T patent/PL3764984T3/pl unknown
- 2019-03-06 CN CN202410141562.1A patent/CN118059054A/zh active Pending
- 2019-03-06 HR HRP20211717TT patent/HRP20211717T1/hr unknown
- 2019-03-06 US US16/970,694 patent/US11717486B2/en active Active
- 2019-03-06 EP EP19708112.8A patent/EP3764984B1/fr active Active
- 2019-03-06 CN CN201980018518.9A patent/CN111936119B/zh active Active
- 2019-03-06 CA CA3094384A patent/CA3094384A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN118059054A (zh) | 2024-05-24 |
| EP3764984B1 (fr) | 2021-08-18 |
| HUE056416T2 (hu) | 2022-02-28 |
| RU2020128269A (ru) | 2022-04-15 |
| ES2898387T3 (es) | 2022-03-07 |
| EP3764984A1 (fr) | 2021-01-20 |
| US11717486B2 (en) | 2023-08-08 |
| DK3764984T3 (da) | 2021-10-18 |
| HRP20211717T1 (hr) | 2022-02-18 |
| CA3094384A1 (fr) | 2019-09-19 |
| IT201800003615A1 (it) | 2019-09-15 |
| WO2019174990A1 (fr) | 2019-09-19 |
| PT3764984T (pt) | 2021-10-15 |
| US20200375909A1 (en) | 2020-12-03 |
| PL3764984T3 (pl) | 2022-02-07 |
| CN111936119A (zh) | 2020-11-13 |
| CN111936119B (zh) | 2024-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA50663A (fr) | Formulations stables d'anticorps anti-récepteur de mort programmée 1 (pd-1) et leur utilisation | |
| MA49043A (fr) | Formulation stable d'anticorps | |
| MA56006A (fr) | Formulations sous-cutanées d'anticorps her2 | |
| PL3784285T3 (pl) | Środki krioprotekcyjne do formulacji cząstek stałych | |
| MA54052A (fr) | Formulation d'anticorps | |
| MA41159A (fr) | Octréotide destiné à être administré par voie orale en association avec d'autres agents thérapeutiques | |
| MA49116A (fr) | Compositions pharmaceutiques contenant de l'insuline | |
| MA54139A (fr) | Formulation d'anticorps | |
| MA52019A (fr) | Schéma posologique de modulateur d'assemblage de capside | |
| MA50047A (fr) | Administration orale d'analogues peptidiques de glp-1 | |
| MA56049A (fr) | Formulations stabilisées contenant des anticorps anti-angptl3 | |
| PL3315117T3 (pl) | Kompozycja do higieny jamy ustnej dostarczająca środki aktywne do pielęgnacji jamy ustnej | |
| MA55362A (fr) | Formulations stabilisées contenant des anticorps anti-il-33 | |
| MA54043A (fr) | Cercueil notamment pour l'inhumation en pleine terre | |
| MA51990A (fr) | Formulations hautement stables d'hormone thyroïdienne dans des capsules molles | |
| EP3768836C0 (fr) | Modèle animal de la maladie d'alzheimer et son utilisation | |
| MA47106A (fr) | Formulations d'anticorps anti-tnf alpha | |
| IL276984B1 (en) | Insecticides and their use | |
| DK3886820T3 (da) | Kapselformuleringer | |
| MA53099A (fr) | Formes d'ivosidénib et compositions pharmaceutiques | |
| FR3028713B1 (fr) | Distributrice autonome de fourrage apte a realiser une litiere dans un batiment d'elevage d'animaux de rente et batiment la comportant | |
| MA52874A (fr) | Formulations/compositions comprenant de l'ibrutinib | |
| MA46568A (fr) | Dosage biologique de formulations d'insuline | |
| MA55809A (fr) | Formulation d'anticorps anti-il-6 | |
| HUE062682T2 (hu) | Ibuprofén tartalmú orális gyógyszerészeti készítmény |